For laboratory research use only. This page summarizes public scientific literature. It is not medical advice and does not describe or endorse human, clinical, or veterinary use.
Chemistry & identity
| CAS Number | 446262-90-4 |
|---|---|
| Molecular Formula | C165H269N47O46 |
| Molecular Weight | 3647.2 g/mol |
| Residue Count | 30 |
| PubChem CID | 91971820 |
Peptide sequence
YXDAIFTQSYRKVLAQLSARKLLQDILSRK
Research context
PubChem describes CID 91971820 as "a maleimido derivative of hGRF(1-29)" (DAC = drug affinity complex via maleimidopropionyl on Lys30). Sequence (30-mer incl. Lys30) taken verbatim from the FDA docket FDA-2024-N-4777 peptide list; X = D-Ala at position 2.
Selected research references
Published peer-reviewed literature on CJC-1295 With DAC. Provided for research-context purposes only; CC Peptides does not make claims about outcomes in humans.
- Prolonged stimulation of growth hormone (GH) and insulin-like growth factor I secretion by CJC-1295, a long-acting analog of GH-releasing hormone, in healthy adults
- Once-daily administration of CJC-1295, a long-acting growth hormone-releasing hormone (GHRH) analog, normalizes growth in the GHRH knockout mouse
- Pulsatile secretion of growth hormone (GH) persists during continuous stimulation by CJC-1295, a long-acting GH-releasing hormone analog
- Activation of the GH/IGF-1 axis by CJC-1295, a long-acting GHRH analog, results in serum protein profile changes in normal adult subjects
CJC-1295 With DAC for laboratory research
CC Peptides supplies CJC-1295 With DAC as a lyophilized reference material with a third-party COA. Ships from California.
View product page →